Scotia Capital Inc. Arbutus Biopharma Corp Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

A detailed history of Scotia Capital Inc. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Scotia Capital Inc. holds 14,740 shares of ABUS stock, worth $52,327. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,740

Previous 18,740 21.34%

Holding current value

$52,327

Previous $57,000 1.75%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.12 - $4.56 $12,480 - $18,240	-4,000 Reduced 21.34%	14,740 $56,000
Q2 2024 Aug 14, 2024	SELL	$2.52 - $3.63 $25,956 - $37,389	-10,300 Reduced 35.47%	18,740 $57,000
Q2 2023 Aug 03, 2023	SELL	$2.24 - $3.06 $336 - $459	-150 Reduced 0.51%	29,040 $66,000
Q1 2023 May 11, 2023	BUY	$2.23 - $3.1 $65,093 - $90,489	29,190 New	29,190 $88,000
Q3 2021 Nov 12, 2021	SELL	$2.65 - $4.62 $30,978 - $54,007	-11,690 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$3.14 - $4.84 $442 - $682	-141 Reduced 1.19%	11,690 $39,000
Q4 2020 Feb 11, 2021	BUY	$2.76 - $4.97 $27 - $49	10 Added 0.08%	11,831 $42,000
Q3 2020 Nov 12, 2020	BUY	$1.75 - $6.2 $229 - $812	131 Added 1.12%	11,821 $37,000
Q1 2020 May 15, 2020	BUY	$1.01 - $3.42 $40 - $136	40 Added 0.34%	11,690 $12,000
Q4 2019 Feb 13, 2020	SELL	$0.87 - $2.89 $6,960 - $23,120	-8,000 Reduced 40.71%	11,650 $32,000
Q3 2019 Nov 14, 2019	SELL	$1.34 - $2.4 $4,020 - $7,200	-3,000 Reduced 13.25%	19,650 $30,000
Q2 2019 Aug 13, 2019	SELL	$1.46 - $4.44 $292 - $888	-200 Reduced 0.88%	22,650 $47,000
Q3 2018 Nov 14, 2018	SELL	$7.85 - $12.35 $48,670 - $76,570	-6,200 Reduced 21.34%	22,850 $216,000
Q4 2017 Feb 13, 2018	SELL	$4.45 - $7.7 $11,570 - $20,020	-2,600 Reduced 8.21%	29,050 $147,000
Q3 2017 Nov 14, 2017	BUY	$3.4 - $7.0 $34,510 - $71,050	10,150 Added 47.21%	31,650 $196,000
Q2 2017 Aug 15, 2017	BUY	N/A	21,500	21,500 $77,000

Others Institutions Holding ABUS

# of Institutions

156

Shares Held

99.6M

Call Options Held

2.31M

Put Options Held

525K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $532M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Arbutus Biopharma Corp Transaction History